Phenex Pharmaceuticals Aktiengesellschaft

Phenex Pharmaceuticals Aktiengesellschaft is a Aktiengesellschaft in Heidelberg, Germany with 2 ISIN-identified securities mapped to its LEI, which is how regulators tie a traded instrument to the issuer behind it.

The LEI has been on record for 10 years, since 11 Feb 2016. That is about 4 years earlier than the median LEI in Germany, which dates from 2019 — an early adopter by local standards.

Annual re-validation is 1637 days overdue: it fell due 11 Feb 2022. An LEI that is not re-validated lapses, which does not invalidate it but marks the reference data as unverified.

The record has not changed since we began archiving it on 6 Jul 2026. Any future change to name, status, address, ownership or renewal date will be captured here, because GLEIF publishes only the current state and superseded values are otherwise lost.

The entity is registered with Commercial Register under registry number HRB 734710, and the LEI itself is issued and maintained by Herausgebergemeinschaft Wertpapier-Mitteilungen Keppler, Lehmann GmbH & Co. KG, one of the Local Operating Units accredited by GLEIF.

Beyond the LEI, 2 ISINs are mapped to this entity in the GLEIF cross-reference files.

No direct accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

No ultimate accounting-consolidating parent is reported, because no controlling person is known. GLEIF requires this to be stated explicitly rather than left blank, so the absence is itself a data point.

The LEI registration is lapsed, and the entity status (active) records whether the legal entity itself still exists. The two are independent: an LEI can lapse while the company trades on, and it can stay issued after the company has been dissolved.